Related Experiment Video

Updated: Oct 23, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

714

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society

Mara Dierssen1,2,3, Yann Herault4, Pablo Helguera5

  • 1Centre for Genomic Regulation, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Molecular Syndromology
|August 23, 2021
PubMed

Insights

Research on Down syndrome (also known as trisomy 21 or T21) is advancing rapidly. Scientists are exploring T21

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Developmental Biology

Background:

  • Down syndrome, or trisomy 21 (T21), research has grown significantly.
  • Understanding T21's impact on cellular and molecular processes is crucial.

Purpose of the Study:

  • To present the latest discoveries from the Third International Conference of the Trisomy 21 Research Society (T21RS).
  • To foster collaboration among scientists, families, and industry representatives.
  • To advance the understanding and amelioration of conditions associated with T21.

Main Methods:

  • The Third International Conference of T21RS convened 429 attendees.
  • Presentations covered diverse research areas including neuroscience, neurology, and cancer.
  • Discussions focused on cellular and molecular mechanisms, cognitive challenges, and comorbidities.

Main Results:

  • Cutting-edge results were shared across multiple scientific disciplines.
  • Progress was demonstrated in understanding T21's effects on brain function and development.
  • New insights into comorbidities like Alzheimer's disease and leukemia were presented.

Conclusions:

  • There is compelling interest and continuous advancement in Down syndrome research.
  • Interdisciplinary approaches are key to understanding and treating T21.
  • Future research directions include therapeutic strategies and biomarker development.
Keywords:
Alzheimer's diseaseBiomarkersDown syndromeIntellectual disabilityLanguage impairmentMouse modelsNeurodevelopmental disordersTrisomy 21 Research Society

More Related Videos

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.3K
Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue07:29

Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue

Published on: May 25, 2011

15.6K

Related Concept Videos

Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
198.3K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Karyotyping01:17

Karyotyping

Overview
64.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
62.5K